Literature DB >> 11454061

Endocytosis and recycling of the complex between CD23 and HLA-DR in human B cells.

S N Karagiannis1, J K Warrack, K H Jennings, P R Murdock, G Christie, K Moulder, B J Sutton, H J Gould.   

Abstract

The presentation of extremely low doses of antigen to T cells is enhanced by immunoglobulin E (IgE)-dependent antigen focusing to CD23, the low-affinity receptor for IgE, expressed on activated B cells. CD23 contains a C-type lectin domain in its extracellular sequence and a targeting signal for coated pits, required for endocytosis, in its cytoplasmic sequence. CD23 is non-covalently associated with the major histocompatibility complex class II antigen, human leucocyte antigen HLA-DR, on the surface of human B cells, but the fate of this complex following endocytosis is unknown. To answer this question we have labelled these proteins on the surface of RPMI 8866 B cells and traced their route through the cytoplasm. Endocytosis mediated by anti-CD23 antibodies (BU38 and MHM6) led to the loss of CD23 from the cells. Endocytosis mediated by an antibody to HLA-DR (CR3/43) or an antigen-IgE complex (NP-BSA-anti-NP IgE), however, led to recycling of the HLA-DR-CD23 complex to the cell surface on a time scale (3-6 hr) consistent with the recycling of HLA-DR in antigen presentation. Along the latter pathway CD23 label was observed in cytoplasmic organelles that resembled the 'compartments for peptide loading' or 'class II vesicles' described by previous authors. Two features of the recycling process may contribute to the efficiency of antigen presentation. Peptide exchange may be facilitated by the proximity of HLA-DR and antigen in peptide loading compartments of the endosomal network. The return of CD23 with HLA-DR to the cell surface may then help to stabilize specific B-cell-T-cell interactions, contributing to T-cell activation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11454061      PMCID: PMC1783243          DOI: 10.1046/j.1365-2567.2001.01238.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  67 in total

1.  Two peptides from CD23, including the inverse RGD sequence and its related peptide, interact with the MHC class II molecule.

Authors:  S Kijimoto-Ochiai; A Noguchi
Journal:  Biochem Biophys Res Commun       Date:  2000-01-27       Impact factor: 3.575

2.  Immunoglobulins cytophilic for human lymphocytes, monocytes, and neutrophils.

Authors:  D A Lawrence; W O Weigle; H L Spiegelberg
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

3.  Intracellular cleavage of newly synthesized low affinity Fc epsilon receptor (Fc epsilon R2) provides a second pathway for the generation of the 28-kDa soluble Fc epsilon R2 fragment.

Authors:  B W Lee; C F Simmons; T Wileman; R S Geha
Journal:  J Immunol       Date:  1989-03-01       Impact factor: 5.422

4.  Antigen processing and intracellular Ia. Possible roles of endocytosis and protein synthesis in Ia function.

Authors:  C V Harding; E R Unanue
Journal:  J Immunol       Date:  1989-01-01       Impact factor: 5.422

5.  Kinetics of internalization and recycling of the asialoglycoprotein receptor in a hepatoma cell line.

Authors:  A L Schwartz; S E Fridovich; H F Lodish
Journal:  J Biol Chem       Date:  1982-04-25       Impact factor: 5.157

6.  A hapten-specific chimaeric IgE antibody with human physiological effector function.

Authors:  M S Neuberger; G T Williams; E B Mitchell; S S Jouhal; J G Flanagan; T H Rabbitts
Journal:  Nature       Date:  1985 Mar 21-27       Impact factor: 49.962

7.  Serum-IgE-facilitated allergen presentation in atopic disease.

Authors:  F L van der Heijden; R J Joost van Neerven; M van Katwijk; J D Bos; M L Kapsenberg
Journal:  J Immunol       Date:  1993-04-15       Impact factor: 5.422

8.  Antigen focusing by specific monomeric immunoglobulin E bound to CD23 on Epstein-Barr virus-transformed B cells.

Authors:  L F Santamaria; R Bheekha; F C van Reijsen; M T Perez Soler; M Suter; C A Bruijnzeel-Koomen; G C Mudde
Journal:  Hum Immunol       Date:  1993-05       Impact factor: 2.850

9.  Binding the low affinity Fc epsilon R on B cells suppresses ongoing human IgE synthesis.

Authors:  E Sherr; E Macy; H Kimata; M Gilly; A Saxon
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

Review 10.  The human IgE network.

Authors:  B J Sutton; H J Gould
Journal:  Nature       Date:  1993-12-02       Impact factor: 49.962

View more
  20 in total

Review 1.  Models of signal transduction through the B-cell antigen receptor.

Authors:  Roland Geisberger; Reto Crameri; Gernot Achatz
Journal:  Immunology       Date:  2003-12       Impact factor: 7.397

Review 2.  CD23/FcεRII: molecular multi-tasking.

Authors:  M Acharya; G Borland; A L Edkins; L M Maclellan; J Matheson; B W Ozanne; W Cushley
Journal:  Clin Exp Immunol       Date:  2010-10       Impact factor: 4.330

3.  CD23 Sheddase A disintegrin and metalloproteinase 10 (ADAM10) is also required for CD23 sorting into B cell-derived exosomes.

Authors:  Joel A Mathews; David R Gibb; Bing-Hung Chen; Peggy Scherle; Daniel H Conrad
Journal:  J Biol Chem       Date:  2010-09-28       Impact factor: 5.157

4.  Murine B cells regulate serum IgE levels in a CD23-dependent manner.

Authors:  Laurence E Cheng; Zhi-En Wang; Richard M Locksley
Journal:  J Immunol       Date:  2010-09-24       Impact factor: 5.422

Review 5.  Beyond immediate hypersensitivity: evolving roles for IgE antibodies in immune homeostasis and allergic diseases.

Authors:  Oliver T Burton; Hans C Oettgen
Journal:  Immunol Rev       Date:  2011-07       Impact factor: 12.988

6.  CD23b isoform expression in human schistosomiasis identifies a novel subset of activated B cells.

Authors:  Daniel Onguru; YanMei Liang; Jennifer Elliot; Pauline Mwinzi; Lisa Ganley-Leal
Journal:  Infect Immun       Date:  2011-06-27       Impact factor: 3.441

Review 7.  Anti-CD23.

Authors:  Lanny J Rosenwasser; Jianfeng Meng
Journal:  Clin Rev Allergy Immunol       Date:  2005-08       Impact factor: 8.667

8.  Isolation and phenotypic characterization of mucosal nasal lymphocytes by direct ex vivo analysis.

Authors:  Christin Wolfram; Claudia Rasche; Heike Audring; Michael Wahls; Margitta Worm
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-09-03       Impact factor: 2.503

Review 9.  ADAM8: a new therapeutic target for asthma.

Authors:  Martin D Knolle; Caroline A Owen
Journal:  Expert Opin Ther Targets       Date:  2009-05       Impact factor: 6.902

Review 10.  Immunoglobulin E, what is it good for?

Authors:  Brian T Kelly; Mitchell H Grayson
Journal:  Ann Allergy Asthma Immunol       Date:  2016-03       Impact factor: 6.347

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.